Biodel Overview

  • Founded
  • 2003

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 39

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 12

  • Investments
  • 1

Biodel General Information

Description

Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules.

Contact Information

Website
www.biodel.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 100 Saw Mill Road
  • Danbury, CT 06810
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biodel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biodel‘s full profile, request access.

Request a free trial

Biodel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates b
Pharmaceuticals
Danbury, CT
39 As of 2014
00000
000000 - 000

000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
000000000000000
Philadelphia, PA
000 As of 0000
00000
00000000 00000

000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
0000000000000
Lexington, MA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biodel Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amicus Therapeutics Formerly VC-backed Philadelphia, PA 000 00000 00000000 00000
000000000 Formerly VC-backed Lexington, MA 00 00000 00000000 00000
0000 000000000000 Formerly VC-backed Bridgewater, NJ 00 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Ardsley, NY 000 00000 000000&0
000000000 Corporate Backed or Acquired Stockholm, Sweden 0 00.000 00000000000
You’re viewing 5 of 45 competitors. Get the full list »

Biodel Board Members (9)

Name Representing Role Since
0000000 0000000 00 Self Board Member 000 0000
000 000000000 00.0 Self Board Member 000 0000
00000 00000 Albireo Board Member 000 0000
You’re viewing 3 of 9 board members. Get the full list »

Biodel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biodel Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biodel‘s full profile, request access.

Request a free trial

Biodel Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 03-Nov-2016 0000000 00 Biotechnology
To view Biodel’s complete acquisitions history, request access »

Biodel Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 03-Nov-2016 0000000 000000 Completed
  • 000000
To view Biodel’s complete exits history, request access »